Skip to main content
Premium Trial:

Request an Annual Quote

Christoph Franz, Richard Lifton, etc.

Roche said that Christoph Franz has been reelected as chairman of the board. Nine other board members were also reelected to one-year terms, while two new board members were elected. 

Rejoining Roche's board are André Hoffmann, Pius Baschera; John Bell; Paul Bulcke; DeAnne Julius; Andreas Oeri; Roche CEO Severin Schwan; Peter Voser; and Beatrice Weder di Mauro. Richard Lifton and Bernhard Poussot were elected as new board members. 

Lifton is the Sterling Professor of Genetics and a professor of medicine at Yale University, where he is also chair of the genetics department. He is a Howard Hughes Medical Institute investigator. 

Poussot is the former chairman and CEO of Wyeth and currently serves on the boards of other organizations including the Max Planck Institute.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.